- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05775588
Långtidseffekter av endobronkialventilimplantation på hjärtfunktion och skelettmuskelfunktion
Långtidseffekter av endobronkial ventilimplantation på hjärtfunktion och skelettmuskelfunktion hos patienter med lungvolymreducerad operation
The goal of this type of study: clinical trial is to evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function.
Participants will undergo Lung volume reduction surgery with endobronchial valve implantation.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Mingming Deng, MD
- Telefonnummer: 86 18801336854
- E-post: isdeng1017@163.com
Studera Kontakt Backup
- Namn: Qin Zhang, MD
- Telefonnummer: 86 18990236167
- E-post: zhangqincmu@163.com
Studieorter
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina, 100029
- Rekrytering
- China-Japan Friendship Hospital
-
Kontakt:
- Gang Hou, Professor
- Telefonnummer: 13840065481
- E-post: hougangcmu@163.com
-
Kontakt:
- Mingming Deng, Doctor
- Telefonnummer: 18801336854
- E-post: isdeng1017@163.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients with Chronic Obstructive Pulmonary Disease
- FEV1 ≤ 45% pred and FEV1/FVC<70%
- TLC>100% pred and RV>175% pred
- CAT score≥18
- Emphysema damage>50%
- Complete interlobar fissure >95% based on quantitative analysis of CT measurement
- No smoking>6 months
- Sign the informed consent form
Exclusion Criteria:
- PaCO2>8.0 kPa, or PaO2<6.0 kPa
- 6-minute walk test<160m
- Obvious chronic bronchitis, bronchiectasis or other infectious pulmonary diseases
- More than 3 hospitalizations for pulmonary infection in the past 12 months before baseline assessment
- Previous lobectomy, LVRS or lung transplantation
- LVEF<45% and or RVSP>50mmHg
- Anticoagulant therapy that cannot be stopped before surgery
- Patients with obvious immune deficiency
- Participated in other lung drug studies within the first 30 days of this study
- Pulmonary nodules requiring intervention
- Any disease or condition that interferes with the completion of the initial or subsequent assessment
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Lungvolymreducerad operationsgrupp
|
the patient would undergo Lung volume reduction surgery with endobronchial valve implantation |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Baseline ventricular volume
Tidsram: Baseline
|
cardiac magnetic resonance imaging |
Baseline
|
|
Ventricular volume (6 months after surgery)
Tidsram: 6 months after surgery
|
cardiac magnetic resonance imaging |
6 months after surgery
|
|
Ventricular volume(12 months after surgery)
Tidsram: 12 months after surgery
|
cardiac magnetic resonance imaging |
12 months after surgery
|
|
Baseline FEV1
Tidsram: Baseline
|
Pulmonary function tests |
Baseline
|
|
FEV1 (6 months after surgery)
Tidsram: 6 months after surgery
|
Pulmonary function tests |
6 months after surgery
|
|
FEV1(12 months after surgery)
Tidsram: 12 months after surgery
|
Pulmonary function tests |
12 months after surgery
|
|
Baseline left Ventricular Ejection Fractions
Tidsram: Baseline
|
Echocardiography |
Baseline
|
|
Left Ventricular Ejection Fractions (6 months after surgery)
Tidsram: 6 months after surgery
|
Echocardiography |
6 months after surgery
|
|
Left Ventricular Ejection Fractions (12 months after surgery)
Tidsram: 12 months after surgery
|
Echocardiography |
12 months after surgery
|
|
Baseline exercise tolerance
Tidsram: Baseline
|
6-minute walk test |
Baseline
|
|
Exercise tolerance (6 months after surgery)
Tidsram: 6 months after surgery
|
6-minute walk test |
6 months after surgery
|
|
Exercise tolerance (12 months after surgery)
Tidsram: 12 months after surgery
|
6-minute walk test |
12 months after surgery
|
|
Baseline health impairment and quality of life of patients Baseline health impairment and quality of life of patients
Tidsram: Baseline
|
St. George's Respiratory Questionnaire |
Baseline
|
|
Health impairment and quality of life of patients (6 months after surgery)
Tidsram: 6 months after surgery
|
St. George's Respiratory Questionnaire |
6 months after surgery
|
|
Health impairment and quality of life of patients (12 months after surgery)
Tidsram: 12 months after surgery
|
St. George's Respiratory Questionnaire |
12 months after surgery
|
|
Baseline cross sectional area of rectus femoris
Tidsram: Baseline
|
Rectus femoris ultrasound |
Baseline
|
|
Cross sectional area of rectus femoris (6 months after surgery)
Tidsram: 6 months after surgery
|
Rectus femoris ultrasound |
6 months after surgery
|
|
Cross sectional area of rectus femoris (12 months after surgery)
Tidsram: 12 months after surgery
|
Rectus femoris ultrasound |
12 months after surgery
|
|
Baseline mmuscle strength of lower limb
Tidsram: Baseline
|
Myometer |
Baseline
|
|
Mmuscle strength of lower limb (6 months after surgery)
Tidsram: 6 months after surgery
|
Myometer |
6 months after surgery
|
|
Mmuscle strength of lower limb (12 months after surgery)
Tidsram: 12 months after surgery
|
Myometer |
12 months after surgery
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2022-NHLHCRF-LX-01-0202-1
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .